Monday , December 18 2017
Home / Letter From The Editor / February 20, 2106

February 20, 2106

dave

When the SGLT-2 drugs first came out, there was a big emphasis put on the UTI side-effect, and many prescribers were hesitant to try the class. This proved to be over-exaggerated and prescribers started using them. Further research showed that they could cause weight loss and lower blood pressure, and then there was a large important study that pointed towards the heart benefits of Jardiance (Empagliflozin). Now another study points to the value of Empagliflozin for preserving beta cells. Click to read a feature by our current intern Jimmy Tran.

We also invite you to check out our monthly series on SGLT-2 specific drugs and become an expert.

Announcements:

Diabetes Summit 2016

DIC Publisher Steve Freed will be attending the GTCbio 2016 Diabetes Summit, to be held April 25-27, 2016 in Boston, MA.  This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently. Click here for more information.

Free CME Courses
Our web site CME resource is back online! Be sure to check out the new CME courses posted there. Courses are currently available on topics including: Advances in the Medical & Surgical Management of Obesity; Diabetic Retinopathy; Strategies to Improve Prevention and Treatment of Diabetes; and more!

dLifeTV.com: Sunday, February 21, 7PM ET

From dLife.com: “dLife explores how diabetes can impact your love life, and what you can do about it. Plus, a mouthwatering souffle that anyone can make from the dLife kitchen.” Sundays live online at dLifeTV.com at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at dLifeTV.com.

*****************************

We can make a difference!

*****************************

Dave Joffe, Editor-in-chief